The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
about
Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysisPrognostic significance of new immunohistochemical markers in refractory classical Hodgkin lymphoma: a study of 59 cases.Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategiesHodgkin's lymphoma therapy: past, present, and future.Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantation.Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphomaLate relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraStem cell transplantation in Hodgkin lymphoma.Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience.Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.Onset risk factors and treatment response features of refractory hodgkin lymphomaDouble high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma.Hematopoietic progenitor cells transplantation for recurrent or refractory Hodgkin's lymphoma.High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future.Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma.High-dose chemotherapy in relapsed or refractory Hodgkin lymphoma patients: a reappraisal of prognostic factors.Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey.Peripheral blood CD4/CD19 cell ratio is an independent prognostic factor in classical Hodgkin lymphoma.Pre-transplant FDG-PET-based survival model in relapsed and refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and auto-SCT.The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas.Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model.
P2860
Q26765151-548DE4B3-07A3-4641-A792-B2F8F12C1D8CQ33485242-F67EF389-E596-4984-84CE-A2C9BEE3BBF7Q33886267-113AA2C3-AFFB-417A-BB68-F50FAAC3CE56Q34296914-109E3EA0-B122-443C-A4CE-C1A158FF13F0Q35194592-1B47E58E-9EA0-4AF4-A851-0844CE8DB5ACQ35705317-4CD3E05D-A2EE-4432-8F35-002A16AB642CQ35717972-BB1CCB23-6445-44C8-A109-CACC22A69AEFQ36752029-D92731D1-43D8-481B-8EF0-614BECFC4325Q37126593-32B559F0-BAE9-4A6F-BAA5-CC31330322A8Q37316657-A80B27D4-9E9D-4436-A266-9F779E598645Q37670264-59B8EE84-3F4B-43CF-99ED-3BA090B8F1F1Q37934952-B231E1E6-BF3E-4606-A17A-64FB78C90FE4Q38099028-5CA7F884-097B-4EC9-8C7E-89D5C1FFDC1DQ38132819-F6E8BBF3-F33E-46E0-879B-90AE78008F71Q38179975-1CF43FD7-BB48-4135-822E-D10CFD040D0CQ42165477-0BEB8531-B721-430A-B97A-4287FEDCB9BDQ44780860-6B663B93-FC0B-4A6A-B50E-006849F0BD81Q50873125-B03B8917-F272-48EA-A7D4-A35A4FB8D039Q51189948-F6B15575-3C21-4D6B-82CF-3655F5CECF92Q51236213-CBBD6631-B945-4416-9223-21285C92E1B1Q53132335-E65D69AC-95E1-4F38-A348-89C883673BF1Q53216024-21D284CA-B196-458F-B0EE-00AC40EFF8D0Q53899679-49073925-B093-4032-B6C5-14A4E19164C6Q55296444-696F920A-827B-469F-8F48-1FE7173FCB4F
P2860
The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The International Prognostic F ...... tic stem cell transplantation.
@ast
The International Prognostic F ...... tic stem cell transplantation.
@en
The International Prognostic F ...... tic stem cell transplantation.
@nl
type
label
The International Prognostic F ...... tic stem cell transplantation.
@ast
The International Prognostic F ...... tic stem cell transplantation.
@en
The International Prognostic F ...... tic stem cell transplantation.
@nl
prefLabel
The International Prognostic F ...... tic stem cell transplantation.
@ast
The International Prognostic F ...... tic stem cell transplantation.
@en
The International Prognostic F ...... tic stem cell transplantation.
@nl
P2093
P356
P1433
P1476
The International Prognostic F ...... tic stem cell transplantation.
@en
P2093
A Kessinger
J O Armitage
P J Bierman
R G Bociek
V L Whalen
P304
P356
10.1093/ANNONC/MDF228
P577
2002-09-01T00:00:00Z